Chicago Children's CRS

Chicago, Illinois 606371470

0 studies enrolling now · 40 studies all time

What they study most

Cytomegalovirus Infections, Dyslipidemia, HIV Infections, HIV Lipodystrophy Syndrome, HIV Seronegativity, HIV-Associated Lipodystrophy Syndrome, Hepatitis B, Influenza, Lipodystrophy, Measles, Mycobacterium Avium-intracellulare Infection, Osteopenia

Studies at this site

• Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected ART Experienced Children and Adolescents — Completed
• Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs — Completed
• Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children — Completed
• Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children — Completed
• A Randomized, Comparative Trial of Zidovudine (AZT) Versus 2',3'-Didehydro-3'-Deoxythymidine (Stavudine; d4T) in Children With HIV Infection — Completed
• A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients — Completed
• Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV Infection — Completed
• Safety, Tolerability and Immune Response to LC002, an Experimental Therapeutic Vaccine, in Adults Receiving HAART — Completed
• A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers — Completed
• Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected Children — Completed
• A Study of Dideoxycytidine Plus Zidovudine (AZT) in HIV-Infected Children Who Have Taken AZT — Completed
• A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease — Completed
• A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV Infection — Completed
• Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents — Completed
• Growth Hormone Treatment of Children With HIV-Associated Growth Failure — Completed
• Ritonavir and Indinavir in Children Failing Other Anti-HIV Treatment — Completed
• Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs — Completed
• Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants — Completed
• Immune System Function Following Vaccination in HIV Infected Children Taking Anti-HIV Drugs — Completed
• Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV — Completed
• Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy — Completed
• A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy — Completed
• A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Children Who Cannot Take Trimethoprim-Sulfamethoxazole — Completed
• The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients — Completed
• The Safety of Zidovudine Plus Interferon-Alpha in HIV-Infected Children — Completed
• A Study of Dideoxyinosine (ddI) in HIV-Infected Children Who Have Not Had Success With Zidovudine or Who Cannot Take Zidovudine — Completed
• A Study of the Safety and Effectiveness of a Chickenpox Vaccine in HIV-Infected Children — Completed
• A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers — Completed
• A Study to Test the Safety of Recombinant Interleukin-2 (rIL-2) in HIV-Infected Children — Completed
• A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group — Completed
• A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected Infants — Completed
• Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and Children — Completed
• A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT — Completed
• Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children — Completed
• Evaluating the Safety and Immunogenicity of a Human Parainfluenza Type 3 (HPIV3) Virus Vaccine in Infants and Children — Completed
• A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth — Completed
• Blood Levels of Abacavir in HIV Infected Adolescents — Completed
• The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV — Completed
• Anti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected Adolescents — Completed
• Factors Affecting Adherence to Anti-HIV Drug Regimens in Children and Adolescents — Completed